Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Assessment of risk of bias Due to the great disparity in study designs (clinical and basic research) available for each candidate biomarkers of interest, we did not use ROC curve analysis as a selection criterion to address robustness, but instead included the presence of at least one study per biological compartment including at least 30 individuals per group as a mandatory criterion
10.1212/WNL.51.2.583
.png)
The FTCs second interim report, released in January 2025, found that the Big 3 PBMs marked up certain specialty generic cancer drugs including imatinib, the generic version of Gleevec by thousands of percent at their affiliated specialty pharmacies [2]
doi: 10.1007/s11427-024-2577-0 214
Thats where my life completely changed for the better, she says
Wirkung verschiedener neuer Cytostatica auf die DNA-Reduplikation und die Proliferationskinetik am Modell des Ehrlich-Lettre'schen Ascites-Tumors
US$ 26.41
US$ 23.57
US$ 22.91
US$ 27.04
US$ 25.67
US$ 23.51
US$ 21.05
US$ 27.42
US$ 26.16
US$ 26.53
US$ 22.76
